⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,734.19
−1.44%
FTSE ADX
9,588.41
−1.17%
TASI
9,695.86
−2.32%
QE Index
8,611.10
−0.37%
S&P 500
7,648.87
−0.19%
Nasdaq 100
29,083.07
+0.43%
Nifty 50
22,600.00
−0.39%
Sensex
73,123.83
−0.17%
KSE-100
162,374.88
−0.95%
DFM:EMIRATESNBD
AED 30.00
−3.47%
ADX:IHC
AED 350.00
−0.57%
SAU:2222
SAR 25.40
−0.70%
DSMD:QNBK
QAR 15.50
−1.02%
NAS:NVDA
$212.99
+0.37%
NYSE:TSM
$419.63
+1.77%
NSE:RELIANCE
₹1,190.00
+0.46%
KAR:OGDC
Rs 298.12
−0.79%
Gold
$4,000.39
−0.60%
Brent
$116.06
+2.81%
BTC
$81,659.00
+0.42%
ETH
$2,404.18
+0.76%
DFM General
5,734.19
−1.44%
FTSE ADX
9,588.41
−1.17%
TASI
9,695.86
−2.32%
QE Index
8,611.10
−0.37%
S&P 500
7,648.87
−0.19%
Nasdaq 100
29,083.07
+0.43%
Nifty 50
22,600.00
−0.39%
Sensex
73,123.83
−0.17%
KSE-100
162,374.88
−0.95%
DFM:EMIRATESNBD
AED 30.00
−3.47%
ADX:IHC
AED 350.00
−0.57%
SAU:2222
SAR 25.40
−0.70%
DSMD:QNBK
QAR 15.50
−1.02%
NAS:NVDA
$212.99
+0.37%
NYSE:TSM
$419.63
+1.77%
NSE:RELIANCE
₹1,190.00
+0.46%
KAR:OGDC
Rs 298.12
−0.79%
Gold
$4,000.39
−0.60%
Brent
$116.06
+2.81%
BTC
$81,659.00
+0.42%
ETH
$2,404.18
+0.76%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Closed
🇸🇦
Saudi Arabia
Tadawul · TASI
Closed
🇶🇦
Qatar
QSE · QE General
Closed
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Open
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Closed
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Markets
›
United States
› NAS
› ACAD
A
ACADIA Pharmaceuticals Inc
NAS:ACAD
Healthcare
CBOEFTSE:MRUT
NASDAQ:NBI
$19.69
−3.05%
Live
In session · ≈
AED 72.31
· Market cap
$3.39B
· Next earnings
Wed 4 Nov
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
ACADIA Pharmaceuticals Inc · News · TradingHolo
ACAD news
Headlines tagged to this company
BU
Acadia Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 4, 2026
BusinessWire · 2 d ago
DO
ACADIA Pharmaceuticals Price Target Maintained With a $35.00/Share by Needham
Dow Jones Newswires · 4 d ago
TR
Needham reiterates Buy rating on Acadia Pharmaceuticals, $35 price target
TradingView · 4 d ago
DO
ACADIA Pharmaceuticals Price Target Cut to $23.00/Share From $49.00 by UBS
Dow Jones Newswires · 10 d ago
DO
ACADIA Pharmaceuticals Price Target Cut to $36.00/Share From $37.00 by RBC Capital
Dow Jones Newswires · 15 d ago
SE
Acadia, Zydus patent litigation case looks resolved, says RBC
Seeking Alpha · 18 d ago
SE
These ten healthcare stocks posted the biggest one-month losses
Seeking Alpha · 22 d ago
TR
Weekly Recap: Analysts cut ACAD targets and remlifanserin safety, efficacy
TradingView · 25 d ago
ST
ACAD Stock Tumbles Today: Analysts Weigh RADIANT Results, Cut Price Targets
stocktwits · 28 d ago
ST
ACAD Stock Clocks Worst Day In 2 Years After Alzheimer’s Psychosis Drug Misses Main Goal — Citi Cuts Drug’s Success Odds To 20%
stocktwits · 29 d ago
BE
Acadia Drug Misses Primary Goal in Alzheimer’s Related Psychosis
benzinga · 29 d ago
SE
Acadia falls after mid-stage trial setback for Alzheimer’s psychosis therapy
seekingalpha · 29 d ago
SE
BofA identifies Russell 2000 stocks positioned for Fed hiking cycles
seekingalpha · 30 d ago
MA
ACADIA Pharmaceuticals Expands DAYBUE, NUPLAZID Reach Ahead of Key Alzheimer's Data
MarketBeat · 72 d ago
ZA
Is ACADIA Pharmaceuticals (ACAD) Outperforming Other Medical Stocks This Year?
Zacks Investment Research · 77 d ago
ZA
Can Acadia (ACAD) Run Higher on Rising Earnings Estimates?
Zacks Investment Research · 78 d ago
ZA
3 Medical Stocks Standing Out After Crushing Q2 Earnings Expectations
Zacks Investment Research · 79 d ago
BU
Acadia Pharmaceuticals Reports Second Quarter 2026 Financial Results
Business Wire · 80 d ago
BU
Acadia Pharmaceuticals to Participate in the Canaccord Genuity 46th Annual Growth Conference
Business Wire · 85 d ago
End of the feed